Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Mais filtros

Medicinas Complementares
Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Nutrients ; 14(17)2022 Aug 30.
Artigo em Inglês | MEDLINE | ID: mdl-36079831

RESUMO

Adolescence is a period of intense growth and endocrine changes, and obesity and insulin-resistance processes during this period have lately been rising. Selenium (Se) homeostasis is related to lipid metabolism depending on the form and dose of Se. This study tests the actions of low-dose selenite and Se nanoparticles (SeNPs) on white (WAT) and brown adipose tissue (BAT) deposition, insulin secretion, and GPx1, IRS-1 and FOXO3a expression in the WAT of adolescent rats as regards oxidative stress, adipocyte length and adipokine secretion. Four groups of male adolescent rats were treated: control (C), low selenite supplementation (S), low SeNP supplementation (NS) and moderate SeNP supplementation (NSS). Supplementation was received orally through water intake; NS and NSS rats received two- and tenfold more Se than C animals, respectively. SeNPs were obtained by reducing Se tetrachloride in the presence of ascorbic acid. For the first time in vivo, it was demonstrated that low selenite supplementation contributed to increased adipogenesis via the insulin signaling pathway and LCN2 modulation, while low SeNP administration prevented fat depots in WAT via the decrease in insulin signaling and FOXO3a autophagy in WAT, lowering inflammation. These effects were independent of GPx1 expression or activity in WAT. These findings provide data for dietary approaches to prevent obesity and/or anorexia during adolescence. These findings may be relevant to future studies looking at a nutritional approach aimed at pre-venting obesity and/or anorexia in adolescence.


Assuntos
Nanopartículas , Selênio , Tecido Adiposo Marrom/metabolismo , Tecido Adiposo Branco/metabolismo , Animais , Anorexia/metabolismo , Dieta Hiperlipídica , Suplementos Nutricionais , Insulina/metabolismo , Secreção de Insulina , Masculino , Obesidade/metabolismo , Ratos , Ácido Selenioso/metabolismo , Selênio/metabolismo , Selênio/farmacologia
2.
Nutr Hosp ; 38(3): 585-591, 2021 Jun 10.
Artigo em Espanhol | MEDLINE | ID: mdl-33666089

RESUMO

INTRODUCTION: Introduction: propolis and its components influence lipid metabolism; however, its effect on body composition and mineral metabolism remains unknown. Objectives: to determine the effect of natural propolis supplementation on body composition, mineral metabolism, and the endocrine function of adipose tissue. Material and methods: twenty albino male Wistar rats (8 weeks old) were divided into two groups of 10 animals each. The rats were fed two different types of diet for 90 days: a standard diet for the control group (group C) and the same standard diet + 2 % propolis (group P). Thyroid hormones, ghrelin, leptin, adiponectin and insulin, non-esterified fatty acids (NEFA) in plasma, body composition (lean mass, fat mass and body water), and mineral deposition in target organs (spleen, brain, heart, lungs, testicles, kidneys and femur) were assessed. Results: thyroid stimulating hormone (TSH), triiodothyronine (T3) and thyroxine (T4) did not show any differences after supplementation with propolis, while ghrelin and adiponectin decreased (p < 0.01 and p < 0.05, respectively) and insulin (p < 0.01), leptin (p < 0.05) and NEFA (p < 0.05) increased when 2 % propolis was supplied, while weight and body fat were reduced (p < 0.05) and lean mass increased. Lastly, the propolis supplement improves calcium deposition in the spleen, lungs, testes, and femur (p < 0.05). Conclusion: propolis supplementation of the diet (2 %) causes a decrease in the secretion of ghrelin and adiponectin, increasing the release of non-esterified fatty acids and the rate of insulin secretion. In addition, propolis supplementation induces an improvement in calcium deposition in target organs without affecting the rest of minerals, which improves body composition by inducing a reduction in weight and visceral adipose tissue, and improvement in lean mass.


INTRODUCCIÓN: Introducción: el propóleo y sus componentes influyen en el metabolismo lipídico; sin embargo, se desconoce su efecto sobre la composición corporal y el metabolismo mineral. Objetivos: determinar el efecto de la suplementación de la dieta con propóleo natural sobre la composición corporal, el metabolismo basal y mineral, y la función endocrina del tejido adiposo. Material y métodos: veinte ratas albinas Wistar macho (8 semanas) se dividieron en dos grupos de 10 animales cada uno. Las ratas fueron alimentadas con dos tipos diferentes de dietas durante 90 días: una dieta estándar para el grupo de control (grupo C) y la misma dieta estándar + un 2 % de propóleo (grupo P). Se determinaron las hormonas tiroideas, la grelina, la leptina, la adiponectina y la insulina, los ácidos grasos no esterificados (AGNE) en el plasma, la composición corporal (masa magra, masa grasa y agua corporal) y el depósito de minerales en órganos diana (bazo, cerebro, corazón, pulmones, testículos, riñones y fémur). Resultados: los niveles plasmáticos de hormona estimulante del tiroides (TSH), triyodotironina (T3) y tiroxina (T4) no mostraron diferencias tras la ingesta del suplemento de propóleo, mientras que los de grelina y adiponectina disminuyeron (p < 0,01 y p < 0,05, respectivamente) y los de insulina (p < 0,01), leptina (p < 0,05) y AGNE (p < 0,05) aumentaron cuando la dieta se suplementó con propóleo al 2 %. Se redujeron el peso y la grasa corporal (p < 0,05), incrementándose la masa magra. Por último, el suplemento de propóleo mejoró el depósito de calcio en el bazo, los pulmones, los testículos y el fémur (p < 0,05). Conclusión: el suplemento de propóleo al 2 % de la dieta produjo una disminución de la secreción de grelina y adiponectina, incrementando la concentración de AGNE y aumentando la tasa de secreción de insulina. Además, el suplemento de propóleo indujo una mejora del depósito de calcio en los órganos diana sin afectar al resto de minerales, lo que en conjunto mejora la composición corporal al inducir una reducción del peso y del tejido adiposo visceral, mejorando la masa magra.


Assuntos
Tecido Adiposo/efeitos dos fármacos , Tecido Adiposo/fisiologia , Composição Corporal/efeitos dos fármacos , Suplementos Nutricionais , Glândulas Endócrinas/efeitos dos fármacos , Glândulas Endócrinas/fisiologia , Minerais/metabolismo , Própole/farmacologia , Animais , Masculino , Ratos , Ratos Wistar
3.
Food Funct ; 11(9): 7523-7531, 2020 Sep 23.
Artigo em Inglês | MEDLINE | ID: mdl-32797125

RESUMO

Bone and energy metabolism are profoundly influenced by exercise. The objective of this study was to determine for the first time whether a short-term supplementation with ubiquinol could have a modulating effect on bone turnover and energy metabolism associated with strenuous exercise. The participants (n = 100 healthy and well-trained firemen) were randomly divided into two groups: ubiquinol group (ubiquinol (200 mg day-1)) and control group (placebo) for two weeks. The protocol consisted of conducting two identical strenuous exercise tests with a rest period between tests of 24 h. Blood samples were collected before supplementation (basal value) (T1), after supplementation (T2), after the first physical exercise test (T3), after 24 h of rest (T4), and after the second physical exercise test (T5). Parathyroid hormone (PTH), osteocalcin (OC), osteoprotegerin (OPG), osteopontin (OPN), sclerotin (SOST), alkaline phosphatase (AP), adrenocorticotropin (ACTH), insulin, leptin, adrenaline, noradrenaline and peroxisome proliferator activated receptor-γ coactivator-1α (PGC-1α) were determined. Our protocol increased ACTH, SOST, PTH and OC levels, while it decreased OPN. This protocol also increased adrenaline, noradrenaline and PCG-1α, and decreased insulin. After ubiquinol supplementation, PTH, OC, OPG, alkaline phosphatase, leptin, insulin, noradrenaline and PGC-1α levels increased in the supplemented group compared to the control group after the exercise protocol. Strenuous exercise has a clear effect on energy metabolism and bone turnover. These effects are modulated by ubiquinol supplementation, which especially increases the biomarkers of bone formation during strenuous exercise. In addition, ubiquinol has a beneficial effect on the mobilization of energy sources, fact that it could represent an ergogenic and physiological advantage for skeletal muscles.


Assuntos
Remodelação Óssea/efeitos dos fármacos , Suplementos Nutricionais/análise , Metabolismo Energético/efeitos dos fármacos , Ubiquinona/análogos & derivados , Hormônio Adrenocorticotrópico/metabolismo , Adulto , Exercício Físico , Teste de Esforço , Humanos , Leptina/genética , Leptina/metabolismo , Masculino , Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/fisiologia , PPAR alfa/genética , PPAR alfa/metabolismo , Ubiquinona/administração & dosagem
4.
Nutr Hosp ; 37(4): 770-775, 2020 Aug 27.
Artigo em Espanhol | MEDLINE | ID: mdl-32762237

RESUMO

INTRODUCTION: Introduction: the use of natural nutritional supplements can be used as a coadjuvant therapy since they have several phytochemicals with potential antioxidant effects that could influence lipid and glycemic metabolism. Objectives: to determine the effect of natural propolis supplementation on lipid metabolism and liver antioxidant activity. Material and methods: 20 male Wistar albino rats (8 weeks) were divided into two groups of 10 animals each. Subsequently, they were fed two different types of diet for 90 days: a standard diet for the control group (diet C) and a standard diet + 2 % propolis (diet P). Hematological and biochemical parameters were assessed. The livers were extracted and washed with saline solution, and the cytosolic fractions were prepared fresh for additional analysis of antioxidant enzymes catalase, superoxide dismutase, glutathione peroxidase, and glutathione reductase. Results: after consuming the diet supplemented with propolis, we found a reduction in glucose (p < 0,01), total cholesterol (p < 0,001), GOT (p < 0,05) and GPT (p < 0,01), whereas the propolis supplement induced an increase in the hepatic activity of SOD (p < 0,001), CAT (p < 0,01) and GR (p < 0,05). Conclusion: the present study reveals that a dietary propolis supplement (2 %) can improve the lipid and glycemic profiles, also increasing antioxidant enzimes and reducing the release of liver transaminases.


INTRODUCCIÓN: Introducción: el uso de suplementos nutricionales naturales puede ser una terapia complementaria ya que tienen fitoquímicos con posibles efectos antioxidantes que pueden mejorar la regulación del metabolismo lipídico y glucémico. Objetivos: determinar el efecto de la suplementación con propóleo natural sobre el metabolismo lipídico y la actividad antioxidante hepática. Material y métodos: 20 ratas albinas Wistar macho (8 semanas) se dividieron en dos grupos de 10 animales cada uno y se sometieron a un período de 90 días en el que se alimentaron con dos tipos diferentes de dietas: estándar para el grupo de control (dieta C) y dieta estándar + 2 % de propóleo (dieta P). Se determinaron los parámetros hematológicos y bioquímicos. Se extrajeron los hígados, se lavaron con solución salina y las fracciones citosólicas se prepararon frescas para análisis adicionales de las enzimas antioxidantes catalasa, superóxido-dismutasa, glutatión-peroxidasa y glutatión-reductasa. Resultados: tras el consumo de la dieta con suplemento de propóleo, encontramos una reducción de la glucosa (p < 0,01), el colesterol total (p < 0,001), la GOT (p < 0,05) y la GPT (p < 0,01), mientras que dicha dieta indujo un incremento en la actividad hepática de SOD (p < 0,001), CAT (p < 0,01) y GR (p < 0,05). Conclusión: el presente estudio revela que el suplemento nutricional de propóleo al 2 % puede mejorar significativamente el perfil lipídic, el glucémico y las enzimas antioxidantes, y reducir la liberación de GOT y GPT hepáticas.


Assuntos
Antioxidantes/farmacologia , Glicemia/efeitos dos fármacos , Metabolismo dos Lipídeos/efeitos dos fármacos , Fígado/efeitos dos fármacos , Fígado/metabolismo , Própole/farmacologia , Animais , Suplementos Nutricionais , Masculino , Modelos Animais , Ratos , Ratos Wistar
5.
Nutrients ; 12(2)2020 Feb 06.
Artigo em Inglês | MEDLINE | ID: mdl-32041223

RESUMO

Strenuous exercise (any activity that expends six metabolic equivalents per minute or more causing sensations of fatigue and exhaustion to occur, inducing deleterious effects, affecting negatively different cells), induces muscle damage and hematological changes associated with high production of pro-inflammatory mediators related to muscle damage and sports anemia. The objective of this study was to determine whether short-term oral ubiquinol supplementation can prevent accumulation of inflammatory mediators and hematological impairment associated to strenuous exercise. For this purpose, 100 healthy and well-trained firemen were classified in two groups: Ubiquinol (experimental group), and placebo group (control). The protocol was two identical strenuous exercise tests with rest period between tests of 24 h. Blood samples were collected before supplementation (basal value) (T1), after supplementation (T2), after first physical exercise test (T3), after 24 h of rest (T4), and after second physical exercise test (T5). Hematological parameters, pro- and anti-inflammatory cytokines and growth factors were measured. Red blood cells (RBC), hematocrit, hemoglobin, VEGF, NO, EGF, IL-1ra, and IL-10 increased in the ubiquinol group while IL-1, IL-8, and MCP-1 decreased. Ubiquinol supplementation during high intensity exercise could modulate inflammatory signaling, expression of pro-inflammatory, and increasing some anti-inflammatory cytokines. During exercise, RBC, hemoglobin, hematocrit, VEGF, and EGF increased in ubiquinol group, revealing a possible pro-angiogenic effect, improving oxygen supply and exerting a possible protective effect on other physiological alterations.


Assuntos
Contagem de Eritrócitos , Exercício Físico/fisiologia , Fadiga , Hematócrito , Hemoglobinas/metabolismo , Transdução de Sinais/fisiologia , Ubiquinona/análogos & derivados , Quimiocina CCL2/metabolismo , Citocinas/metabolismo , Método Duplo-Cego , Teste de Esforço , Feminino , Humanos , Mediadores da Inflamação/metabolismo , Peptídeos e Proteínas de Sinalização Intercelular/metabolismo , Interleucina-1/metabolismo , Masculino , Músculo Esquelético/metabolismo , Músculo Esquelético/patologia , Consumo de Oxigênio/efeitos dos fármacos , Ubiquinona/farmacologia
6.
Nutrients ; 12(2)2020 Feb 05.
Artigo em Inglês | MEDLINE | ID: mdl-32033312

RESUMO

During the first days of life, premature infants have physiological difficulties swallowing, thereby missing out on the benefits of breastfeeding. The aim of this study is to assess the effects of oropharyngeal mother's milk administration in the inflammatory signaling of extremely premature infants. Neonates (n = 100) (<32 week's gestation and/or <1500 g) were divided into two groups: mother's milk group (n = 48), receiving 0.2 mL of oropharyngeal mother's milk every 4 h for the first 15 days of life, and a control group (n = 52), not receiving oropharyngeal mother's milk. Serum concentrations of interleukin (IL) IL-6, IL-8, IL-10, IL-1ra, tumor necrosis factor alpha (TNF-α), and interferón gamma (IFN-γ) were assessed at 1, 3, 15, and 30 days of postnatal life. Maternal and neonatal outcomes were collected. The rate of common neonatal morbidities in both groups was similar. The mother's milk group achieved full enteral feeding earlier, and showed a decrease in Il-6 on days 15 and 30, in IL-8 on day 30, and in TNF-α and INF-γ on day 15, as well as an increase in IL-1ra on days 3 and 15 and in IL-10 on day 30. Oropharyngeal mother's milk administration for 15 days decreases the pro-inflammatory state of preterm neonates and provides full enteral nutrition earlier, which could have a positive influence on the development of the immune system and inflammatory response, thereby positively influencing other developmental outcomes.


Assuntos
Colostro/imunologia , Nutrição Enteral/métodos , Lactente Extremamente Prematuro/imunologia , Doenças do Prematuro/terapia , Leite Humano/imunologia , Biomarcadores/sangue , Citocinas/sangue , Feminino , Humanos , Recém-Nascido , Inflamação , Gravidez , Resultado do Tratamento
7.
Pediatr Allergy Immunol ; 30(2): 234-241, 2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-30444546

RESUMO

BACKGROUND: The immune system of preterm infants is immature, being a significant cause of morbidity and mortality, particularly in the preterm infant. Oropharyngeal colostrum administration could be an immunomodulatory aid. Our aim was to evaluate the effect of oropharyngeal colostrum on the serum levels of immunoglobulins, lactoferrin, and resistin during the first month of life and to track the clinical outcome of the neonates. METHODS: One hundred preterm neonates born at <32 weeks of gestation and/or weighing < 1500 g and assisted in the Neonatal Intensive Care Unit were enrolled and divided into two groups: colostrum (n = 48) and control (n = 52). The subjects assigned to the colostrum group received 0.2 mL of colostrum (oropharyngeal route) every 4 hours for the first 15 days of life, and if mothers have inability to breastfeed, they were included in the control group (no oropharyngeal colostrum). Serum concentrations of IgA, IgM, and IgG1, lactoferrin, and resistin were assessed in both groups at 1, 3, 15, and 30 days of life. Clinical data during hospitalization were collected. RESULTS: IgA and IgM increased in preterm neonates who were administered colostrum for 15 and 30 days. Lactoferrin increased after 30 days, and resistin increased after 15 days of supplying oropharyngeal colostrum. The colostrum group underwent full enteral nutrition before, and no differences were observed in the common neonatal morbidities. CONCLUSION: Oropharyngeal colostrum administration is safe in preterm neonates and improves their immunologic profile, showing a potential role as an immunomodulatory agent.


Assuntos
Colostro/imunologia , Imunoterapia/métodos , Recém-Nascido Prematuro/imunologia , Administração Oral , Biomarcadores/sangue , Aleitamento Materno , Nutrição Enteral/estatística & dados numéricos , Feminino , Humanos , Imunoglobulinas/sangue , Lactente , Recém-Nascido , Doenças do Prematuro/epidemiologia , Lactoferrina/sangue , Masculino , Resistina/sangue
8.
J Hum Lact ; 34(4): 789-798, 2018 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-29601268

RESUMO

BACKGROUND: Although exercise reduces systemic inflammation, information regarding its influence on human milk is scarce or inexistent. Research Aim: The aim of this study was to investigate the influence of an exercise intervention during pregnancy on colostrum and mature human milk inflammatory markers. METHODS: The authors conducted a pseudorandomized controlled trial. The exercise group followed a concurrent aerobic and strength training, three 60-minutes sessions per week, from the 17th gestational week until delivery. For the specific aims of this study, only women able to produce enough milk were included for data analyses, resulting in 24 exercise and 23 control women. Colostrum and mature human milk proinflammatory and anti-inflammatory cytokines (fractalkine, interleukin [IL]-1ß, IL-6, IL-8, IL-10, interferon [IFN]-γ, and tumor necrosis factor [TNF]-α) were measured using Luminex xMAP technology. RESULTS: The mothers who followed the exercise program had 36% lower IL-8 and 27% lower TNF-α concentrations in their colostrum than those in the control group ( p < .05 and p < .01, respectively). The colostrum from mothers who followed the exercise program also presented borderline significant 22% lower IL-6 ( p < .100). The mature milk from mothers who followed the exercise program had 30% greater fractalkine ( p = .05) and borderline significant 20% higher IL-10 ( p = .100). The exercise intervention did not affect IFN-γ concentrations. CONCLUSIONS: This concurrent exercise program promoted a less proinflammatory profile in human milk, especially in colostrum. Moreover, it might increase mature human milk fractalkine, which could induce a greater neurodevelopment and neuroprotection in the newborn. This trial was registered at ClinicalTrials.gov (NCT02582567) on October 20, 2015.


Assuntos
Colostro/metabolismo , Exercício Físico/fisiologia , Inflamação/enzimologia , Leite Humano/enzimologia , Adulto , Quimiocina CX3CL1/análise , Colostro/enzimologia , Citocinas/análise , Feminino , Humanos , Inflamação/sangue , Inflamação/metabolismo , Interferon gama/análise , Interleucina-10/análise , Interleucina-1beta/análise , Interleucina-6/análise , Interleucina-8/análise , Leite Humano/metabolismo , Gravidez , Fator de Necrose Tumoral alfa/análise
9.
Food Res Int ; 105: 654-667, 2018 03.
Artigo em Inglês | MEDLINE | ID: mdl-29433260

RESUMO

Many beneficial properties have been attributed to the Mediterranean diet. Over the years, researchers have attempted to learn which foods and which food components are responsible for good health. One of these components is hydroxytyrosol, an important phenolic compound present in olive oil. Hydroxytyrosol is a molecule of high interest to the pharmaceutical industry due to its anti-inflammatory and antimicrobial qualities its role against cardiovascular diseases and metabolic syndrome and for its neuroprotection, antitumour, and chemo modulation effects. The interest in this molecule has led to wide research on its biological activities, its beneficial effects in humans and how to synthetize new molecules from hydroxytyrosol. This review describes the vast range of information about hydroxytyrosol, focusing on its involvement in biological mechanisms and modulation effects on different pathologies. This review also serves to highlight the role of hydroxytyrosol as a nutraceutical and as a potential therapeutic agent.


Assuntos
Anti-Infecciosos/uso terapêutico , Anti-Inflamatórios/uso terapêutico , Antineoplásicos/uso terapêutico , Antioxidantes/uso terapêutico , Dieta Saudável , Dieta Mediterrânea , Suplementos Nutricionais , Azeite de Oliva/química , Álcool Feniletílico/análogos & derivados , Animais , Anti-Infecciosos/efeitos adversos , Anti-Infecciosos/isolamento & purificação , Anti-Inflamatórios/efeitos adversos , Anti-Inflamatórios/isolamento & purificação , Antineoplásicos/efeitos adversos , Antineoplásicos/isolamento & purificação , Antioxidantes/efeitos adversos , Antioxidantes/isolamento & purificação , Suplementos Nutricionais/efeitos adversos , Humanos , Álcool Feniletílico/efeitos adversos , Álcool Feniletílico/isolamento & purificação , Álcool Feniletílico/uso terapêutico
10.
J Agric Food Chem ; 65(20): 4057-4065, 2017 May 24.
Artigo em Inglês | MEDLINE | ID: mdl-28475318

RESUMO

To date, no studies are available about adipose tissue modifications during anemia recovery; therefore, the aim of this study is to provide detailed information about adipose tissue homeostasis during anemia recovery with fermented milks. Forty male Wistar rats were placed on a pre-experimental period of 40 days, divided in two groups (normal-Fe diet and Fe-deficient diet). Then rats were fed fermented goat or cow milk-based diets with normal-Fe content during 30 days. Ghrelin and adiponectin decreased in both groups of animals fed fermented goat milk, whereas leptin and NEFA increased. UCP-1 decreased in anemic rats fed either fermented milk, and irisin greatly increased in both groups of animals fed fermented goat milk. Fermented goat milk reduces adiposity, inducing leptin elevation and ghrelin reduction. Conversely, plasma adiponectin concentrations decreased in animals fed fermented goat milk, showing an inverse correlation with NEFA, an important marker of lipid mobilization, indicating increased lipolysis. Irisin up-regulation in animals fed fermented goat milk contributes to a favorable metabolic profile and the browning of adipose tissue during anemia recovery.


Assuntos
Adiposidade , Anemia/dietoterapia , Produtos Fermentados do Leite/microbiologia , Anemia/fisiopatologia , Animais , Composição Corporal , Bovinos , Produtos Fermentados do Leite/análise , Suplementos Nutricionais/análise , Fermentação , Cabras , Humanos , Lactobacillus delbrueckii/metabolismo , Masculino , Ratos , Ratos Wistar , Streptococcus thermophilus/metabolismo
11.
Biofactors ; 42(6): 612-622, 2016 Nov 12.
Artigo em Inglês | MEDLINE | ID: mdl-27193497

RESUMO

Studies about Coenzyme Q10 (CoQ10 ) supplementation on strenuous exercise are scarce, especially those related with oxidative stress associated with physical activity and virtually nonexistent with the reduced form, Ubiquinol. The objective of this study was to determine, for the first time, whether a short-term supplementation with Ubiquinol can prevent oxidative stress associated to strenuous exercise. The participants (n = 100 healthy and well trained, but not on an elite level) were classified in two groups: Ubiquinol (experimental group), and placebo group (control). The protocol consisted of conducting two identical strenuous exercise tests with a rest period between tests of 24 h. Blood and urine samples were collected from the participants before supplementation (basal value) (T1), after supplementation (2 weeks) (T2), after first physical exercise test (T3), after 24 h of rest (T4), and after second physical exercise test (T5).The increase observed in the lactate, isoprostanes, DNA damage, and hydroperoxide levels reveals the severity of the oxidative damage induced by the exercise. There was a reduction in the isoprostanes, 8-OHdG, oxidized LDL, and hydroperoxydes in the supplemented Ubiquinol group, an increase in total antioxidant status, fat soluble antioxidant (both plasma and membrane), and CAT activity. Also, NO in the Ubiquinol-supplemented group was maintained within a narrow range. Oxidative stress induced by strenuous exercise is accumulative and increases transiently in subsequent sessions of physical activity. A short-term supplementation (2 weeks) with Ubiquinol (200 mg/day) before strenuous exercise, decreases oxidative stress and increases plasma NO, fact that could improve endothelial function, energetic substrate supply, and muscle recovery after strenuous exercise. © 2016 BioFactors, 42(6):612-622, 2016.


Assuntos
Antioxidantes/administração & dosagem , Estresse Oxidativo/efeitos dos fármacos , Esforço Físico/efeitos dos fármacos , Ubiquinona/análogos & derivados , Adulto , Suplementos Nutricionais , Esquema de Medicação , Voluntários Saudáveis , Humanos , Masculino , Pessoa de Meia-Idade , Treinamento Resistido , Ubiquinona/administração & dosagem
12.
Molecules ; 21(3): 264, 2016 Feb 25.
Artigo em Inglês | MEDLINE | ID: mdl-26927041

RESUMO

Nowadays, there are some molecules that have shown over the years a high capacity to act against relevant pathologies such as cardiovascular disease, neurodegenerative disorders or cancer. This article provides a brief review about the origin, bioavailability and new research on curcumin and synthetized derivatives. It examines the beneficial effects on health, delving into aspects such as cancer, cardiovascular effects, metabolic syndrome, antioxidant capacity, anti-inflammatory properties, and neurological, liver and respiratory disorders. Thanks to all these activities, curcumin is positioned as an interesting nutraceutical. This is the reason why it has been subjected to several modifications in its structure and administration form that have permitted an increase in bioavailability and effectiveness against different diseases, decreasing the mortality and morbidity associated to these pathologies.


Assuntos
Anti-Inflamatórios/uso terapêutico , Antineoplásicos Fitogênicos/uso terapêutico , Antioxidantes/uso terapêutico , Cardiotônicos/uso terapêutico , Curcuma/química , Curcumina/uso terapêutico , Fármacos Neuroprotetores/uso terapêutico , Animais , Anti-Inflamatórios/síntese química , Anti-Inflamatórios/isolamento & purificação , Antineoplásicos Fitogênicos/síntese química , Antineoplásicos Fitogênicos/isolamento & purificação , Antioxidantes/síntese química , Antioxidantes/isolamento & purificação , Disponibilidade Biológica , Cardiotônicos/síntese química , Cardiotônicos/isolamento & purificação , Doenças Cardiovasculares/tratamento farmacológico , Curcumina/síntese química , Curcumina/isolamento & purificação , Humanos , Inflamação , Neoplasias/tratamento farmacológico , Doenças Neurodegenerativas/tratamento farmacológico , Fármacos Neuroprotetores/síntese química , Fármacos Neuroprotetores/isolamento & purificação , Plantas Medicinais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA